ECM
CLX icon

Everence Capital Management’s Clorox CLX Stock Holding History

Everence Capital Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,240
Closed -$439K – 865
2026
Q1 		$439K Buy
4,240
+899
+27% +$102K 0.03% 420
2025
Q4 		$337K Buy
3,341
+371
+12% +$40.3K 0.02% 542
2025
Q3 		$366K Buy
+2,970
New +$369K 0.02% 514
2025
Q1 		– Sell
-1,690
Closed -$274K – 795
2024
Q4 		$274K Sell
1,690
-2,660
-61% -$435K 0.02% 623
2024
Q3 		$709K Hold
4,350
– – 0.04% 315
2024
Q2 		$643K Hold
4,350
– – 0.04% 319
2024
Q1 		$666K Hold
4,350
– – 0.04% 330
2023
Q4 		$620K Sell
4,350
-2,800
-39% -$373K 0.04% 332
2023
Q3 		$937K Buy
7,150
+5,130
+254% +$780K 0.07% 224
2023
Q2 		$320K Hold
2,020
– – 0.03% 500
2023
Q1 		$320K Sell
2,020
-10
-0.5% -$1.5K 0.03% 512
2022
Q4 		$285K Buy
+2,030
New +$288K 0.02% 568
2022
Q1 		– Sell
-2,790
Closed -$486K – 744
2021
Q4 		$486K Buy
+2,790
New +$465K 0.04% 432
2021
Q2 		– Sell
-1,450
Closed -$280K – 729
2021
Q1 		$280K Hold
1,450
– – 0.03% 585
2020
Q4 		$293K Buy
+1,450
New +$300K 0.03% 534
2019
Q4 		– Sell
-2,852
Closed -$433K – 677
2019
Q3 		$433K Hold
2,852
– – 0.07% 307
2019
Q2 		$437K Hold
2,852
– – 0.07% 302
2019
Q1 		$458K Hold
2,852
– – 0.08% 275
2018
Q4 		$440K Hold
2,852
– – 0.1% 218
2018
Q3 		$429K Hold
2,852
– – 0.09% 250
2018
Q2 		$386K Hold
2,852
– – 0.08% 266
2018
Q1 		$380K Hold
2,852
– – 0.08% 263
2017
Q4 		$424K Buy
+2,852
New +$388K 0.09% 242

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Everence Capital Management's CLX Position: Q2 2026 in Review

Everence Capital Management sold out of Clorox (CLX) in Q2 2026, closing a stake of 4,240 shares — an estimated $439K sold.

Everence Capital Management first reported a position in CLX in Q4 2017 and held it in 23 quarters. The position peaked at $937K in Q3 2023. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Everence Capital Management reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Everence Capital Management sold 4,240 Clorox shares in Q2 2026, an estimated $439K.
  • Everence Capital Management first reported a position in Clorox in Q4 2017 and held it in 23 quarters.
  • Everence Capital Management's Clorox position peaked at $937K in Q3 2023.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.